US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 0.953
  • -0.021-2.15%
Close Jun 14 16:00 ET
  • 0.950
  • -0.003-0.27%
Post 19:47 ET
167.16MMarket Cap-8663P/E (TTM)

Rigel Pharmaceuticals Key Stats

Rigel Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

29.53M

+13.29%
EPS(YoY)

-0.05

+37.50%

Buy

May 31, 2024

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.876M--
--2024/Q2-- / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--
Aug 1, 20232023/Q226.886M / 25.704M--
May 2, 20232023/Q126.070M / 24.073M--
Mar 7, 20232022/Q451.278M / 26.640M--
Nov 3, 20222022/Q322.410M / 22.610M--
Aug 2, 20222022/Q229.819M / 23.655M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.876M--
--2024/Q2-- / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--
Aug 1, 20232023/Q226.886M / 25.704M--
May 2, 20232023/Q126.070M / 24.073M--
Mar 7, 20232022/Q451.278M / 26.640M--
Nov 3, 20222022/Q322.410M / 22.610M--
Aug 2, 20222022/Q229.819M / 23.655M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 31, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg